<DOC>
	<DOCNO>NCT02370849</DOCNO>
	<brief_summary>In open-label , single-center , small sample size , randomise , parallel-group , control study , investigator aim assess efficacy safety addition nimotuzumab CS chemotherapy patient previously untreated advanced gastric adenocarcinoma . Sixty-two patient require randomly assign ( 1:1 ) group . The control regimen ( CS chemotherapy ) recommend standard first-line regimen advance adenocarcinoma stomach gastroesophageal junction japan .</brief_summary>
	<brief_title>Cisplatin S-1 With Without Nimotuzumab Untreated Advanced Gastric Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1. provision write informed consent ; 2. male female ; age ≥ 18 year ; 3 . Histologically verify , untreated , metastatic locally advanced inoperable adenocarcinoma signet ring cell carcinoma stomach gastroesophageal junction ; 4 . At least one radiographically document measurable lesion accord Response Evaluation Criteria In Solid Tumors Version 1.1 ( RECIST1.1 ) Criteria ; 5 . An Eastern Cooperative Oncology Group ( ECOG ) performance status 02 ; life expectancy ≥ 3months ; 6 . No previous palliative chemotherapy ; 7 . Adequate function vital organ : white blood cell ( WBC ) ≥ 4.0×109/L , neutrophil ( ANA ) ≥ 1.5 × 109/L , platelet ≥ 100 × 109/L , hemoglobin ≥ 90g/L ( blood transfusion permit necessary ) , serum bilirubin ≤ 1 time upper normal limit ( UNL ) , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 2.5 time UNL , alkaline phosphatase ( AKP ) ≤ 5 time UNL , creatinine ( Cr ) ≤ 1 time UNL , normal electrocardiography ( ECG ) . 1. pregnant lactating patient , reproductive woman without effective contraception ; 2 . Patients nonmeasurable disease : small lesion ( long diameter &lt; 10mm pathological lymph node ≥ 10 &lt; 15mm short axis ) , Bone lesion , leptomeningeal disease , ascites , pleural pericardial effusion , lymphangitic involvement skin lung ; abdominal masses/abdominal organomegaly identify physical exam measurable reproducible image technique . 3 . Symptomatic brain metastasis ; 4 . Patients clinically severe comorbidity include diabetes mellitus , hypertension , heart disease , chronic active hepatitis ( HBV carrier enrol circumstance permit ) ; 5 . No previous radiotherapy measurable lesion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>nimotuzumab</keyword>
	<keyword>gastric adenocarcinoma</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>S-1</keyword>
	<keyword>epidermal growth factor receptor</keyword>
</DOC>